84. Sarcoidosis
143 clinical trials,   221 drugs   (DrugBank: 79 drugs),   82 drug target genes,   165 drug target pathways

Searched query = "Sarcoidosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03793439
(ClinicalTrials.gov)
May 15, 20192/1/2019Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent SarcoidosisTofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent SarcoidosisSarcoidosis, Pulmonary;Sarcoidosis Lung;SarcoidosisDrug: Tofacitinib 5mg Oral Tablet [Xeljanz] 16 week trial;Diagnostic Test: Spirometry;Genetic: RNA Sequencing;Diagnostic Test: Laboratory testing;Drug: Corticosteroid;Drug: Tofacitinib 5mg [Xeljanz] 1 year open-label extensionOregon Health and Science UniversityPfizerRecruiting18 Years89 YearsAll5Phase 1United States
2NCT03910543
(ClinicalTrials.gov)
April 11, 20194/4/2019Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma AnnulareOpen-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma AnnulareCutaneous Sarcoidosis;Granuloma AnnulareDrug: Tofacitinib 5 mg twice dailyYale UniversityPfizerActive, not recruiting18 YearsN/AAll15Phase 1United States